4 ms·
> I see no financial incentives for drug companies to discourage it. Then you’re not looking hard enough. You don’t think endless booster shots are an incentiv
by ImpressiveWebs 5y ago
> I see no financial incentives for drug companies to discourage it.
Then you’re not looking hard enough. You don’t think endless booster shots are an incentive to dismiss Ivermectin? Discouraging Ivermectin means, not billions, but trillions in revenue.
And that’s not even considering the fact that the vaccines could never be legally approved for emergency use if Ivermectin works.
- jjeaff 5y agoFalse. The existence of a therapeutic does not block approval of other treatments or vaccines. In fact, there were multiple emergency authorized therapeutics for c19 when the made the eua for the vaccine. And no one is talking about endless vaccines. We now have a 3rd booster for at-risk populations. It's possibly/likely that if they extend that recommendation to the rest of the population that 3 doses may be all that is needed for long term, strong immunity. Just like there are 3 doses for hep B and several other vaccines.